NCT05406973

Brief Summary

LASIK is the most commonly performed refractive surgery worldwide. It has been shown to be safe and effective procedure with predictable results over long term follow ups. With the advancement of technology, sub-Bowman keratomileusis allows thin flap of approximately 100 microns thickness thus preserving thicker stromal bed as compared to conventional LASIK. The femtosecond laser corneal flap has th advantage of producing a flap of uniform thickness, adjustable flap diameter, relatively few complications. The disadvantages of this procedure is the high cost of surgery, development of bubbles in the corneal layer and anterior chamber which may affect pupil trackingduring the procedure. Despite the emergence of femtosecond laser-assisted flap creation, mechanical microkeratomes remain the preferred choice in the majority of developing countries. Recent studies have shown that SBK corneal flap has the same advantages as femtosecond laser flap regarding flap uniformity, regularity, and accuracy with less suction time and cost, but with its specific complications as well.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 13, 2017

Completed
2 years until next milestone

Study Start

First participant enrolled

October 1, 2019

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
5 months until next milestone

First Posted

Study publicly available on registry

June 7, 2022

Completed
Last Updated

March 20, 2023

Status Verified

March 1, 2023

Enrollment Period

2.3 years

First QC Date

September 13, 2017

Last Update Submit

March 16, 2023

Conditions

Keywords

LASIK, SBK, femtolaser, flap creation, myopia

Outcome Measures

Primary Outcomes (1)

  • flap thickness accuracy

    comparison between the accuracy of the SBK microkeratome versus Femtosecond laser in flap creation during LASIK surgery for myopia, 1 month after surgery using anterior segment OCT

    1 month post operative

Secondary Outcomes (1)

  • Visual Acuity measurment

    1day, 1 week, 1 month after surgery

Study Arms (2)

Moria SBK microkeratome

OTHER

Comparative non randomized Interventional clinical study between SBK microkeratome versus femtosecond laser in flap creation during LASIK surgery for myopia

Device: SBK microkeratome versus femtosecond laser in flap creation

200-kHz Femtosecond laser system

OTHER

Comparative non randomized Interventional clinical study between SBK microkeratome versus femtosecond laser in flap creation during LASIK surgery for myopia

Device: SBK microkeratome versus femtosecond laser in flap creation

Interventions

prospective comparative non randomized interventional clinical study

200-kHz Femtosecond laser systemMoria SBK microkeratome

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Myopes (from -1 to -9), with astigmatism up to -4, normal corneal topography, central corneal thickness (CCT) more than 500 microns, and stable refraction for at least 12 months.

You may not qualify if:

  • CCT less than 500 microns, any ocular pathologies, one eyed patients, history of systemic disease, intraoperative complications, and abnormal corneal topography.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eye Care Center

Maadi, Cairo Governorate, Egypt

Location

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Officials

  • Yehia Salah El Din, MD

    Professor of Ophthalmology, Kasr Al Aini

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ophthalmologist

Study Record Dates

First Submitted

September 13, 2017

First Posted

June 7, 2022

Study Start

October 1, 2019

Primary Completion

December 31, 2021

Study Completion

December 31, 2021

Last Updated

March 20, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations